Ignite Planners, LLC Bristol Myers Squibb CO Transaction History

Ignite Planners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$47.98 - $54.4 $6,429 - $7,289	-134 Reduced 3.35%	3,868 $209,000
Q4 2023 Jan 08, 2024	SELL	$48.48 - $57.85 $103,941 - $124,030	-2,144 Reduced 34.88%	4,002 $205,000
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $99,570 - $111,335	-1,720 Reduced 21.87%	6,146 $356,000
Q2 2023 Jul 11, 2023	BUY	$63.71 - $70.74 $11,467 - $12,733	180 Added 2.34%	7,866 $503,000
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $38,571 - $43,749	587 Added 8.27%	7,686 $532,000
Q4 2022 Feb 02, 2023	BUY	$68.48 - $81.09 $26,501 - $31,381	387 Added 5.77%	7,099 $510,000
Q3 2022 Oct 12, 2022	BUY	$0.13 - $76.84 $123 - $72,844	948 Added 16.45%	6,712 $472,000
Q2 2022 Jul 15, 2022	SELL	$72.62 - $79.98 $66,883 - $73,661	-921 Reduced 13.78%	5,764 $434,000
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $38,547 - $46,222	627 Added 10.35%	6,685 $506,000
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $324,890 - $378,746	6,058 New	6,058 $393,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ignite Planners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ignite Planners, LLC with notifications on news.